1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. BIOCON LTD.
Biocon Ltd. NSE: BIOCON | BSE: 532523
Strong Performer, Getting Expensive
Download real time
398.75 1.75 (0.44%)
New 52W High today
6.4M
NSE+BSE Volume

NSE 18 Jul, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
US FDA Approval
Biocon gets US FDA approval for Kirsty insulin drug with annual sales of $1.9 billion See details

Biocon Ltd. - Financial Ratios